Aug 24 (Reuters) - Life sciences company Precision Therapeutics Inc filed with U.S. regulators on Friday to raise up to $80.5 million in an initial public offering of common stock. JP Morgan Securities Inc, Piper Jaffray & Co and JMP Securities LLC are underwriting the IPO, the Pittsburgh, Pennsylvania-based company told the U.S. Securities and Exchange Commission in a preliminary prospectus.
